Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fragments of NKp44 and NKp46 for targeting viral-infected and tumor cells

Fragments of NKp44 and NKp46 for targeting viral-infected and tumor cells

US Patent 7825085 · Granted Nov 2, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies specific to human t-cell immunoglobulin and ITIM domain (TIGIT)2024
Non-cytotoxic modified cells and use thereof2024
Antibodies specific to human NECTIN42024
Antibodies specific to human T-cell immunoglobulin and ITIM domain (TIGIT)2021
Attenuated or inactivated pathogenic Escherichia coli for treating urogenital ca2021
Antibodies specific to human poliovirus receptor (PVR)2021
Anti-NKP46 antibodies, toxin conjugates, and therapeutic use of same2020
Diagnostic and therapeutic methods and their application in amyotrophic lateral 2018
Peptides derived from cytotoxicity receptor natural killer protein 44 NKP442016
Method of treating type 1 diabetes by administering NKp46 polypeptide2015
Method of treating type 1 diabetes by administering NKp46 polypeptide2015
Compositions of HSP60 peptides and viral antigens for vaccination and diagnosis2014